棘白菌素在ICU患者侵袭性念珠菌病治疗中的定位,非粒缺成人患者侵袭性念珠菌感染指南-EFISG/ESCMIDguidelines2012,血培养酵母菌阳性(AII)或经验治疗(CIIu),开始抗真菌治疗,Stronglyrecommended:棘白菌素(AI),Moderatelyrecommended:L-AMBor伏立康唑(BI),Marginallyrecommended:氟康唑orABLC(CI),Notrecommeded(D):AMB伊曲康唑泊沙康唑联合治疗,Cornelyetal.ClinMicrobInfect2012;DOI:10.1111/1469-0691.12039,u-uncontrolledtrials,非粒缺成人患者侵袭性念珠菌感染指南变迁:ESCMIDvsIDSAguideline,Cornelyetal.ClinMicrobInfect2012;DOI:10.1111/1469-0691.12039,CID2011:52（15February）e56-e93,WhynotFluconazole？,Whyechinocandins？,Cornelyet
